In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group
Muscle Recovery and Performance Muscle tears whether from training, injury, or surgery respond well to BPC-157
The funder had no role in the design, data collection, data analysis, and reporting of this study
Wait a few seconds after full injection before withdrawing the needle at the same angle it was inserted
Cagrilintide is also studied in research literature in combination with GLP-1 receptor agonists, while pramlintide is typically studied alone